Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
900 | 11301 | 40.8 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
512 | 3 | BRCA1//BRCA2//FANCONI ANEMIA | 21435 |
900 | 2 | BRCA1//BRCA2//FANCONI ANEMIA | 11301 |
471 | 1 | BRCA2//BRCA1//HEREDITARY BREAST CANCER | 3398 |
3284 | 1 | FANCONI ANEMIA//FANCONI ANAEMIA//FANCD2 | 2020 |
5107 | 1 | BRCA1//BARD1//BRCA2 | 1672 |
8040 | 1 | HEREDITARY PROSTATE CANCER//RNASEL//8Q24 | 1300 |
10345 | 1 | PARP INHIBITORS//OLAPARIB//SYNTHETIC LETHALITY | 1071 |
15199 | 1 | CHEK2//PALB2//CHK2 | 726 |
17719 | 1 | CANC GENET EPIDEMIOL//SERV CIRUGIA GEN ESPECIALIDADES//UNIT MOL BASES GENET RISK GENET TESTING | 586 |
18965 | 1 | CONTRALATERAL PROPHYLACTIC MASTECTOMY//BILATERAL BREAST CANCER//CONTRALATERAL BREAST CANCER | 528 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BRCA1 | authKW | 2801530 | 14% | 64% | 1633 |
2 | BRCA2 | authKW | 2081644 | 9% | 72% | 1064 |
3 | FANCONI ANEMIA | authKW | 1084594 | 5% | 77% | 525 |
4 | PARP INHIBITORS | authKW | 284628 | 2% | 57% | 186 |
5 | HEREDITARY BREAST CANCER | authKW | 278601 | 1% | 65% | 160 |
6 | BRCA | authKW | 259297 | 2% | 45% | 213 |
7 | CANC GENET EPIDEMIOL | address | 239483 | 1% | 53% | 168 |
8 | CHEK2 | authKW | 218851 | 1% | 86% | 94 |
9 | FANCONI ANAEMIA | authKW | 190048 | 1% | 80% | 88 |
10 | OLAPARIB | authKW | 178119 | 1% | 82% | 80 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 96769 | 48% | 1% | 5414 |
2 | Genetics & Heredity | 33601 | 23% | 1% | 2647 |
3 | Cell Biology | 4194 | 12% | 0% | 1320 |
4 | Biochemistry & Molecular Biology | 2031 | 15% | 0% | 1748 |
5 | Hematology | 1968 | 5% | 0% | 545 |
6 | Obstetrics & Gynecology | 1371 | 4% | 0% | 467 |
7 | Urology & Nephrology | 519 | 3% | 0% | 311 |
8 | Medicine, Research & Experimental | 324 | 3% | 0% | 366 |
9 | Pathology | 243 | 2% | 0% | 231 |
10 | Public, Environmental & Occupational Health | 223 | 3% | 0% | 373 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC GENET EPIDEMIOL | 239483 | 1% | 53% | 168 |
2 | FAMILY CANC CLIN | 169823 | 1% | 53% | 119 |
3 | INT HEREDITARY CANC | 160065 | 1% | 48% | 123 |
4 | UNIT MOL BASES GENET RISK GENET TESTING | 140452 | 1% | 68% | 76 |
5 | PROGRAM CANC GENET | 109235 | 1% | 41% | 99 |
6 | FAMILIAL BREAST OVARIAN CANC | 90129 | 0% | 70% | 48 |
7 | CANC GENET TUMOR BIOL | 81028 | 0% | 73% | 41 |
8 | ONTARIO CANC GENET NETWORK | 80437 | 0% | 65% | 46 |
9 | UNIT MED GENET | 79329 | 1% | 27% | 110 |
10 | CLIN CANC GENET | 78277 | 1% | 37% | 79 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FAMILIAL CANCER | 94330 | 2% | 20% | 175 |
2 | BREAST CANCER RESEARCH AND TREATMENT | 73730 | 4% | 6% | 446 |
3 | HEREDITARY CANCER IN CLINICAL PRACTICE | 51562 | 1% | 32% | 59 |
4 | BREAST CANCER RESEARCH | 24848 | 1% | 7% | 142 |
5 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 17200 | 2% | 3% | 202 |
6 | HUMAN MUTATION | 11635 | 1% | 3% | 132 |
7 | NATURE GENETICS | 8864 | 1% | 3% | 129 |
8 | JOURNAL OF MEDICAL GENETICS | 8530 | 1% | 2% | 137 |
9 | PROSTATE | 7004 | 1% | 2% | 110 |
10 | HUMAN MOLECULAR GENETICS | 6907 | 1% | 2% | 161 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRCA1 | 2801530 | 14% | 64% | 1633 | Search BRCA1 | Search BRCA1 |
2 | BRCA2 | 2081644 | 9% | 72% | 1064 | Search BRCA2 | Search BRCA2 |
3 | FANCONI ANEMIA | 1084594 | 5% | 77% | 525 | Search FANCONI+ANEMIA | Search FANCONI+ANEMIA |
4 | PARP INHIBITORS | 284628 | 2% | 57% | 186 | Search PARP+INHIBITORS | Search PARP+INHIBITORS |
5 | HEREDITARY BREAST CANCER | 278601 | 1% | 65% | 160 | Search HEREDITARY+BREAST+CANCER | Search HEREDITARY+BREAST+CANCER |
6 | BRCA | 259297 | 2% | 45% | 213 | Search BRCA | Search BRCA |
7 | CHEK2 | 218851 | 1% | 86% | 94 | Search CHEK2 | Search CHEK2 |
8 | FANCONI ANAEMIA | 190048 | 1% | 80% | 88 | Search FANCONI+ANAEMIA | Search FANCONI+ANAEMIA |
9 | OLAPARIB | 178119 | 1% | 82% | 80 | Search OLAPARIB | Search OLAPARIB |
10 | PROPHYLACTIC MASTECTOMY | 168126 | 1% | 73% | 85 | Search PROPHYLACTIC+MASTECTOMY | Search PROPHYLACTIC+MASTECTOMY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KARAMI, F , MEHDIPOUR, P , (2013) A COMPREHENSIVE FOCUS ON GLOBAL SPECTRUM OF BRCA1 AND BRCA2 MUTATIONS IN BREAST CANCER.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 166 | 94% | 14 |
2 | MOLDOVAN, GL , D'ANDREA, AD , (2009) HOW THE FANCONI ANEMIA PATHWAY GUARDS THE GENOME.ANNUAL REVIEW OF GENETICS. VOL. 43. ISSUE . P. 223-249 | 128 | 83% | 272 |
3 | THOMPSON, LH , HINZ, JM , (2009) CELLULAR AND MOLECULAR CONSEQUENCES OF DEFECTIVE FANCONI ANEMIA PROTEINS IN REPLICATION-COUPLED DNA REPAIR: MECHANISTIC INSIGHTS.MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. VOL. 668. ISSUE 1-2. P. 54 -72 | 186 | 72% | 94 |
4 | PAUL, A , PAUL, S , (2014) THE BREAST CANCER SUSCEPTIBILITY GENES (BRCA) IN BREAST AND OVARIAN CANCERS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 19. ISSUE . P. 605-618 | 153 | 83% | 15 |
5 | PRAKASH, R , ZHANG, Y , FENG, WR , JASIN, M , (2015) HOMOLOGOUS RECOMBINATION AND HUMAN HEALTH: THE ROLES OF BRCA1, BRCA2, AND ASSOCIATED PROTEINS.COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY. VOL. 7. ISSUE 4. P. - | 143 | 53% | 53 |
6 | NAROD, SA , FOULKES, WD , (2004) BRCA1 AND BRCA2: 1994 AND BEYOND.NATURE REVIEWS CANCER. VOL. 4. ISSUE 9. P. 665-676 | 130 | 80% | 455 |
7 | CECCALDI, R , SARANGI, P , D'ANDREA, AD , (2016) THE FANCONI ANAEMIA PATHWAY: NEWYPLAYERS AND NEW FUNCTIONS.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 17. ISSUE 6. P. 337 -349 | 99 | 73% | 11 |
8 | YUAN, FH , SONG, LM , QIAN, LY , HU, JJ , ZHANG, YB , (2010) ASSEMBLING AN ORCHESTRA: FANCONI ANEMIA PATHWAY OF DNA REPAIR.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 15. ISSUE . P. 1131-1149 | 172 | 79% | 3 |
9 | LYNCH, HT , KOSOKO-LASAKI, O , LESLIE, SW , RENDELL, M , SHAW, T , SNYDER, C , D'AMICO, AV , BUXBAUM, S , ISAACS, WB , LOEB, S , ET AL (2016) SCREENING FOR FAMILIAL AND HEREDITARY PROSTATE CANCER.INTERNATIONAL JOURNAL OF CANCER. VOL. 138. ISSUE 11. P. 2579 -2591 | 115 | 85% | 3 |
10 | GUIDUGLI, L , CARREIRA, A , CAPUTO, SM , EHLEN, A , GALLI, A , MONTEIRO, ANA , NEUHAUSEN, SL , HANSEN, TVO , COUCH, FJ , VREESWIJK, MPG , (2014) FUNCTIONAL ASSAYS FOR ANALYSIS OF VARIANTS OF UNCERTAIN SIGNIFICANCE IN BRCA2.HUMAN MUTATION. VOL. 35. ISSUE 2. P. 151 -164 | 118 | 92% | 12 |
Classes with closest relation at Level 2 |